http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2424796-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6379feda6e2eb9af0653088fc5870448 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 |
filingDate | 2010-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2011-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aef109eac4b63901ae49efb01678cd62 |
publicationDate | 2011-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2424796-C1 |
titleOfInvention | Method of treating toxic optic neuropathy, induced by long intake of codeine-containing medications |
abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, in particular to ophthalmology, and deals with treatment of toxic optic neuropathy, induced by long intake of codeine-containing medications. For this purpose, as the first stage, carried out is complex treatment for 10 days by intravenous introduction of medication nootropyl in dose 5-10 ml, intramuscular introduction of medication glutoxim 2.0 ml, milgamma 2.0 ml, parabulbar introduction of dexason 0.5 ml, introduction of heptral in dose I tablet 3 times per day and 10 sessions of transcutaneous electrostimulation of optic nerves, starting from the first day, I session per day, then starting from the 11-th day, as the second stage, for the following 10 days carried out are intravenous introduction of cerebrolysin 5-10 ml, intramuscular introduction of proserin 0.5-1.0 ml, mexidol 1.0-2.0 ml daily, parabalbar introduction of emoxipin 0.5 ml, introduction of pantogam 0.25 g 3 times per day, as well as carrying out 10 sessions of magnetic stimulation of optic nerves, starting from the 11-th day from beginning of treatment, one session per day. n EFFECT: increase of visual functions in case of said pathology. n 2 ex, 1 tbl |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2494775-C1 |
priorityDate | 2010-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.